Profil
Ms. Elhan Webb was previously employed as a Senior Vice President-Investor Relations by Karyopharm Therapeutics, Inc., a Vice President-Investor Relations by Rubius Therapeutics, Inc., a Head-Investor Relations & External Communications by Radius Health, Inc., a Head-Investor Relations by ALX Oncology Holdings, Inc., and an Investor Relations Officer by Roche Holding AG.
She received her undergraduate degree from Bogazici University and an MBA from the University of Southern California.
Anciens postes connus de Elhan Webb
| Sociétés | Poste | Fin |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Investor Relations Contact | - |
| KARYOPHARM THERAPEUTICS INC. | Investor Relations Contact | - |
| ROCHE HOLDING AG | Public Communications Contact | - |
| RUBIUS THERAPEUTICS | Investor Relations Contact | - |
| RADIUS HEALTH, INC. | Investor Relations Contact | - |
Formation de Elhan Webb
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Roche Holding AG
Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bogazici University
Bogazici University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Rubius Therapeutics, Inc.
Rubius Therapeutics, Inc. BiotechnologyHealth Technology Develops red cell therapeutics for cancer treatment | Health Technology |
ALX Oncology Holdings, Inc.
ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer | Health Technology |
















